Santen Pharmaceutical Co., Ltd. - stock earnings
SNPHF Quarterly earnings
Date | Earnings | Revenue |
---|---|---|
2023Q4 | 52.0 million USD | 546.2 million USD |
2023Q3 | 59.4 million USD | 491.5 million USD |
2023Q2 | 72.0 million USD | 500.8 million USD |
2023Q1 | 8.4 million USD | 596.7 million USD |
2022Q4 | 45.6 million USD | 541.2 million USD |
2022Q3 | -198.7 million USD | 438.7 million USD |
2022Q2 | 48.9 million USD | 480.6 million USD |
2022Q1 | 64.8 million USD | 576.5 million USD |
2021Q4 | 43.8 million USD | 582.6 million USD |
2021Q3 | 62.2 million USD | 572.9 million USD |
2021Q2 | 66.4 million USD | 584.9 million USD |
2021Q1 | -127.4 million USD | 612.2 million USD |
2020Q4 | 70.2 million USD | 609.1 million USD |
2020Q3 | 71.9 million USD | 581.9 million USD |
2020Q2 | 57.3 million USD | 533.2 million USD |
2020Q1 | 30.9 million USD | 548.3 million USD |
2019Q4 | 65.6 million USD | 583.6 million USD |
2019Q3 | 62.7 million USD | 555.0 million USD |
2019Q2 | 59.3 million USD | 548.9 million USD |
2019Q1 | 77.5 million USD | 549.8 million USD |
2018Q4 | 81.5 million USD | 533.4 million USD |
2018Q3 | 66.4 million USD | 510.4 million USD |
2018Q2 | 62.0 million USD | 511.2 million USD |
2018Q1 | 74.3 million USD | 529.3 million USD |
2017Q4 | 107.2 million USD | 512.3 million USD |
2017Q3 | 55.4 million USD | 487.5 million USD |
2017Q2 | 79.6 million USD | 499.6 million USD |
2017Q1 | 29.0 million USD | 433.3 million USD |
2016Q4 | 61.7 million USD | 451.8 million USD |
2016Q3 | 52.2 million USD | 472.6 million USD |
2016Q2 | 71.3 million USD | 486.7 million USD |
2016Q1 | 31.0 million USD | 410.2 million USD |
2015Q4 | 51.7 million USD | 426.2 million USD |
2015Q3 | 301.3 million USD | 416.3 million USD |
2015Q2 | 61.5 million USD | 391.4 million USD |
2015Q1 | 65.4 million USD | 374.9 million USD |
2014Q4 | 59.4 million USD | 376.0 million USD |
2014Q3 | 49.1 million USD | 349.6 million USD |
2014Q2 | 36.8 million USD | 332.1 million USD |
2014Q1 | 16.8 million USD | 386.0 million USD |
2013Q4 | 60.8 million USD | 378.2 million USD |
2013Q3 | 35.1 million USD | 357.3 million USD |
2013Q2 | 56.5 million USD | 348.5 million USD |
2013Q1 | 25.3 million USD | 325.3 million USD |
2012Q4 | 59.6 million USD | 366.7 million USD |
2012Q3 | 60.6 million USD | 370.5 million USD |
2012Q2 | 53.9 million USD | 352.5 million USD |
2012Q1 | 29.1 million USD | 340.1 million USD |
2011Q4 | 62.6 million USD | 381.9 million USD |
2011Q3 | 57.1 million USD | 377.1 million USD |
2011Q2 | 68.5 million USD | 345.0 million USD |
2011Q1 | 80.1 million USD | 345.3 million USD |
2010Q4 | 66.3 million USD | 346.0 million USD |
2010Q3 | 56.0 million USD | 330.7 million USD |
2010Q2 | 51.8 million USD | 296.5 million USD |
2010Q1 | 26.5 million USD | 259.7 million USD |
2009Q4 | 49.2 million USD | 292.4 million USD |
2009Q3 | 57.0 million USD | 331.8 million USD |
2009Q2 | 68.0 million USD | 304.2 million USD |
2009Q1 | 24.4 million USD | 240.5 million USD |
2008Q4 | 43.9 million USD | 282.0 million USD |
2008Q3 | 33.8 million USD | 252.2 million USD |
SNPHF Yearly earnings
Date | Earnings | Revenue |
---|---|---|
2023 | -112.5 million USD | 2.1 billion USD |
2022 | 222.7 million USD | 2.2 billion USD |
2021 | 61.7 million USD | 2.3 billion USD |
2020 | 218.6 million USD | 2.2 billion USD |
2019 | 288.8 million USD | 2.1 billion USD |
2018 | 331.2 million USD | 2.1 billion USD |
2017 | 206.3 million USD | 1.8 billion USD |
2016 | 475.0 million USD | 1.7 billion USD |
2015 | 200.3 million USD | 1.3 billion USD |
2014 | 166.3 million USD | 1.4 billion USD |
2013 | 175.4 million USD | 1.3 billion USD |
2012 | 208.6 million USD | 1.4 billion USD |
2011 | 256.6 million USD | 1.3 billion USD |
2010 | 200.2 million USD | 1.2 billion USD |
2009 | 102.3 million USD | 1.0 billion USD |
2008 | 126.7 million USD | 1.0 billion USD |
2007 | 111.6 million USD | 853.1 million USD |
2006 | 110.6 million USD | 835.7 million USD |
2005 | 102.9 million USD | 865.3 million USD |
SNPHF
Price: $9.45
Dividend Yield: 2.49%
Forward Dividend Yield: 5.08%
Payout Ratio: 101.28%
Dividend Per Share: 0.48 USD
Earnings Per Share: 0.47 USD
P/E Ratio: 21.15
Exchange: PNK
Sector: Healthcare
Industry: Drug Manufacturers - General
Market Capitalization: 3.5 billion
Average Dividend Frequency: 2
Years Paying Dividends: 20
DGR3: -2.03%
DGR5: 30.00%
DGR10: 30.00%